We are live on
!
Find out more
ECU
Eisler Capital (UK) Portfolio holdings
AUM
$21.7B
1-Year Est. Return
0.34%
This Fund
S&P 500
This Quarter
Est. Return
-4.38%
1 Year Est. Return
+0.34%
3 Year Est. Return
+3.95%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.9B
AUM Growth
+$2.05B
(+15%)
Cap. Flow
-$330M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
41.23%
Holding
492
New
136
Increased
155
Reduced
139
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$176M |
| 2 |
Microsoft
MSFT
|
+$156M |
| 3 |
NVIDIA
NVDA
|
+$148M |
| 4 |
Amazon
AMZN
|
+$54.9M |
| 5 |
Meta Platforms (Facebook)
META
|
+$51.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CREC
Crescera Capital Acquisition Corp Class A Ordinary Shares
CREC
|
+$48.5M |
| 2 |
CVS Health
CVS
|
+$14.3M |
| 3 |
Nucor
NUE
|
+$12.7M |
| 4 |
Wells Fargo
WFC
|
+$12.1M |
| 5 |
Phillips 66
PSX
|
+$10M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 6% |
| 2 | Technology | 5.92% |
| 3 | Consumer Discretionary | 1.92% |
| 4 | Communication Services | 1.65% |
| 5 | Industrials | 0.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
CALL
Applied Materials
AMAT
$419B
| $765K | ﹤0.01% |
+5,527
| New | +$793K |
|
402
Pfizer
PFE
$149B
| $763K | ﹤0.01% |
+23,008
| New | +$814K |
|
403
CALL
Blackrock
BLK
$175B
| $759K | ﹤0.01% |
+1,174
| New | +$820K |
|
404
PUT
Mondelez International
MDLZ
$80.1B
| $757K | ﹤0.01% |
+10,910
| New | +$786K |
|
405
CALL
Ferrari
RACE
$71.6B
| $754K | ﹤0.01% |
+2,553
| New | +$793K |
|
406
CALL
Intuitive Surgical
ISRG
$132B
| $754K | ﹤0.01% |
+2,579
| New | +$805K |
|
|
407
CALL
Mondelez International
MDLZ
$80.1B
| $746K | ﹤0.01% |
+10,744
| New | +$774K |
|
408
CALL
Zoetis
ZTS
$32.4B
| $743K | ﹤0.01% |
+4,271
| New | +$775K |
|
409
CALL
American Express
AXP
$231B
| $733K | ﹤0.01% |
+4,911
| New | +$803K |
|
410
CALL
Gilead Sciences
GILD
$162B
| $723K | ﹤0.01% |
9,643
-25,357
| -72% | -$1.95M |
|
|
MRSH
411
PUT
Marsh
MRSH
$92.2B
| $713K | ﹤0.01% |
+3,749
| New | +$719K |
|
412
Snap
SNAP
$8.83B
| $711K | ﹤0.01% |
+79,813
| New | +$834K |
|
413
CALL
Booking.com
BKNG
$156B
| $705K | ﹤0.01% |
+5,700
| New | +$690K |
|
|
MRSH
414
CALL
Marsh
MRSH
$92.2B
| $705K | ﹤0.01% |
+3,703
| New | +$710K |
|
415
Enbridge
ENB
$113B
| $695K | ﹤0.01% |
20,932
+12,594
| +151% | +$447K |
|
416
CALL
Analog Devices
ADI
$184B
| $691K | ﹤0.01% |
3,947
-54,853
| -93% | -$10.1M |
|
417
PUT
Regeneron Pharmaceuticals
REGN
$79.5B
| $666K | ﹤0.01% |
+809
| New | +$636K |
|
418
CALL
American Tower
AMT
$79.8B
| $662K | ﹤0.01% |
+4,027
| New | +$736K |
|
419
PUT
Vertex Pharmaceuticals
VRTX
$123B
| $656K | ﹤0.01% |
+1,886
| New | +$660K |
|
|
420
CALL
CVS Health
CVS
$123B
| $632K | ﹤0.01% |
+9,045
| New | +$641K |
|
|
SCHW
421
CALL
Charles Schwab
SCHW
$187B
| $623K | ﹤0.01% |
+11,348
| New | +$686K |
|
|
422
CALL
Vertex Pharmaceuticals
VRTX
$123B
| $622K | ﹤0.01% |
+1,789
| New | +$626K |
|
423
PUT
Cigna
CI
$72.7B
| $621K | ﹤0.01% |
+2,171
| New | +$619K |
|
424
CALL
Stryker
SYK
$129B
| $618K | ﹤0.01% |
+2,260
| New | +$648K |
|
|
425
CVS Health
CVS
$123B
| $610K | ﹤0.01% |
8,732
-202,175
| -96% | -$14.3M |
|
Similar funds
EAM
AA
SA
WPL
ECU
RJT
SI
FPCG
Eisler Capital (UK)'s Q3 2023 Portfolio in Review
As of Q3 2023, Eisler Capital (UK) held 492 positions worth $15.9B, up 15% from $13.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Eisler Capital (UK)'s Q3 2023 filing shows 136 new, 155 increased, 139 reduced and 49 closed positions. Its largest new stake was Mastercard: 109,600 shares worth $43.4M. The largest sale was Crescera Capital Acquisition Corp Class A Ordinary Shares, an estimated $48.5M.
By sector, the portfolio is most concentrated in Financials at 6% of assets, up from 1.6% a quarter earlier, followed by Technology and Consumer Discretionary.
- Eisler Capital (UK)'s largest Q3 2023 buy was Mastercard: 109,600 shares worth $43.4M.
- Eisler Capital (UK) added most to Apple in Q3 2023, an estimated $176M increase.
- Eisler Capital (UK)'s biggest Q3 2023 reduction was CVS Health, cutting an estimated $14.3M.
- Eisler Capital (UK) fully exited Crescera Capital Acquisition Corp Class A Ordinary Shares in Q3 2023, selling an estimated $48.5M.
- Eisler Capital (UK)'s ten largest holdings make up 41% of its $15.9B portfolio in Q3 2023.
- Eisler Capital (UK) opened 136 new positions and closed 49 in Q3 2023.
- Eisler Capital (UK)'s portfolio value rose 15% quarter-over-quarter to $15.9B.
Based on Eisler Capital (UK)'s 13F filing for Q3 2023, filed 13 Nov 2023.